Clinical and technical considerations for mediastinal Hodgkin lymphoma protontherapy based on a single-center early experience

CONCLUSION: Despite notable dosimetric superiority over photon radiotherapy and excellent clinical tolerance, lack of availability of protontherapy facilities limit implementation of mediastinal Hodgkin lymphoma protontherapy. Additionally, strict selection criteria must be defined.PMID:34275748 | DOI:10.1016/j.canrad.2021.06.016

Source: Cancer Radiotherapie - July 19, 2021 Category: Cancer & Oncology Authors: P Loap F Goudjil R Dendale Y Kirova Source Type: research